Meet Biovian at Lyckad Läkemedelsutveckling in Stockholm

news-releasesBiovian Ltd
May 29th 2013

Biovian, the GMP contract manufacturer of biopharmaceuticals is delighted to be attending Lyckad Läkemedelsutveckling on May 30th 2013.

Meet Biovian’s CEO, Dr. Knut Ringbom at the event which is taking place at the Grand Hôtel, Stockholm, Sweden. Delegates are invited to visit Biovian’s stand where Dr. Ringbom will be available for in-depth discussions.

The event will help industry professionals and experts to learn about the technologies that can transform drug development as well as allowing attendees to get an insight into changes in regulations and how they could be affected.

About Biovian
From Gene to Finished vial

Biovian is a one-stop-shop in GMP contract manufacturing of biopharmaceuticals covering services from early development to finished vial. Biovian’s 2300 m2 facilities are EMA and FDA certified for cGMP production of investigational and commercial products.

Biovian GMP services:
• Microbial fermentation
• Mammalian cell culture
• Viral vector production
• Protein purification
• Formulation
• Aseptic Fill & Finish
• Analytical Quality Control Services
• Stability studies
• Master cell banking
• Drug product labelling, packaging, storage and QP release

Biovian development services:
• Cell line Development
• Process Development
• Analytical Development

Contact:
Biovian Ltd
Tel: +358 2 27488 77
Email: [email protected]

For more information or to discuss Biovian attending Lyckad Läkemedelsutveckling please contact Biovian directly.